Nuvectis Pharma (NVCT)

• Market cap: $160M
• 1 day: 2.97%
• 5 days: 5.76%
• 1 month: -2.95%
• 3 months: -4.44%
• 6 months: -35.4%
• Year to date: 15.77%
• 1 year: 23.81%
• 5 years: 92%
• 10 years: 92%
• Sector: Healthcare
• Industry: Biotechnology

About: Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Employees: 13